Literature DB >> 25577729

Evaluating the performance of the Framingham Diabetes Risk Scoring Model in Canadian electronic medical records.

Morteza Mashayekhi1, Franklyn Prescod2, Bharat Shah2, Linying Dong2, Karim Keshavjee3, Aziz Guergachi2.   

Abstract

OBJECTIVE: The objective of this study was to evaluate the performance of the Framingham Diabetes Risk Scoring Model (FDRSM) in a Canadian population, using the Canadian Primary Care Sentinel Surveillance Network (CPCSSN) database.
METHODS: We analyzed the records of 571 631 patients, between the ages of 45 and 64, between 2002 and 2005, by extracting the most recent laboratory and examination results, including age, sex, body mass index, fasting blood glucose, high-density lipoprotein, triglycerides and blood pressure. We calculated the risk scores of these patients based on the FDRSM. We tracked these patients for 8 years to find out whether or not they were diagnosed with diabetes. We used the area under the receiver operating characteristics curve (AROC) to estimate the discrimination capability of the FDRSM on our study sample and compared it with the AROC reported in the original Framingham diabetes study.
RESULTS: The AROC for our main research sample of 1970 patients for whom all risk factors and follow-up data were available was 78.6% compared to the AROC of 85% reported in the FDRSM. We found that 70.1% of our main sample had risks lower than 3%; 16.3% had risks between 3% and 10%; and 13.6% had risks greater than 10% for diabetes over the following 8-year period.
CONCLUSIONS: The discrimination capability of the FDRSM Canadian electronic medical records is fair. However, building a more accurate model for predicting diabetes based on the characteristics of Canadian patients is highly recommended.
Copyright © 2015 Canadian Diabetes Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Canadian population; Framingham offspring study; diabetes mellitus; diabète sucré; dossiers médicaux électroniques; electronic medical records; population canadienne; prediabetes; prédiabète; étude Framingham offspring study

Mesh:

Year:  2015        PMID: 25577729     DOI: 10.1016/j.jcjd.2014.10.006

Source DB:  PubMed          Journal:  Can J Diabetes        ISSN: 1499-2671            Impact factor:   4.190


  7 in total

1.  Prognostic Modeling and Prevention of Diabetes Using Machine Learning Technique.

Authors:  Sajida Perveen; Muhammad Shahbaz; Karim Keshavjee; Aziz Guergachi
Journal:  Sci Rep       Date:  2019-09-24       Impact factor: 4.379

2.  Predictive models for diabetes mellitus using machine learning techniques.

Authors:  Hang Lai; Huaxiong Huang; Karim Keshavjee; Aziz Guergachi; Xin Gao
Journal:  BMC Endocr Disord       Date:  2019-10-15       Impact factor: 2.763

3.  Development and Validation of a Risk-Score Model for Type 2 Diabetes: A Cohort Study of a Rural Adult Chinese Population.

Authors:  Ming Zhang; Hongyan Zhang; Chongjian Wang; Yongcheng Ren; Bingyuan Wang; Lu Zhang; Xiangyu Yang; Yang Zhao; Chengyi Han; Chao Pang; Lei Yin; Yuan Xue; Jingzhi Zhao; Dongsheng Hu
Journal:  PLoS One       Date:  2016-04-12       Impact factor: 3.240

4.  A Systematic Machine Learning Based Approach for the Diagnosis of Non-Alcoholic Fatty Liver Disease Risk and Progression.

Authors:  Sajida Perveen; Muhammad Shahbaz; Karim Keshavjee; Aziz Guergachi
Journal:  Sci Rep       Date:  2018-02-01       Impact factor: 4.379

5.  A Hybrid Approach for Modeling Type 2 Diabetes Mellitus Progression.

Authors:  Sajida Perveen; Muhammad Shahbaz; Muhammad Sajjad Ansari; Karim Keshavjee; Aziz Guergachi
Journal:  Front Genet       Date:  2020-01-07       Impact factor: 4.599

6.  Development and validation of a new diabetes index for the risk classification of present and new-onset diabetes: multicohort study.

Authors:  Shinje Moon; Ji-Yong Jang; Yumin Kim; Chang-Myung Oh
Journal:  Sci Rep       Date:  2021-08-03       Impact factor: 4.379

7.  Development of Various Diabetes Prediction Models Using Machine Learning Techniques.

Authors:  Juyoung Shin; Jaewon Kim; Chanjung Lee; Joon Young Yoon; Seyeon Kim; Seungjae Song; Hun-Sung Kim
Journal:  Diabetes Metab J       Date:  2022-03-11       Impact factor: 5.893

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.